	ABO-incompatibility and hepatocellular carcinoma recurrence after living donor liver transplantation: stratified by tumor burden. Transpl Int Kang WH, Hwang S, Moon DB, Kim KH, Ahn CS, Ha TY, Song GW, Jung DH, Park GC, Yoon YI, Na BG, Kim SH, Kim SM, Lee SG. PMID: 42609286 [PubMed - indexed for MEDLINE]
	Liver sinusoidal endothelial cells in liver diseases and hepatocellular carcinoma: molecular mechanisms, physiology, and therapies. Mol Biomed Yan M, Cui Y, Xiang Q. PMID: 42606689 [PubMed - indexed for MEDLINE]
	Cuproptosis in hepatocellular carcinoma: bridging copper homeostasis with therapeutic horizons. Mol Biol Rep Fan S, Wang A, Peng R, Cao J, Tu D, Su B, Zhang J, Jin S, Jiang G, Zhang C, Bai DS. PMID: 42606662 [PubMed - indexed for MEDLINE]
	Risk of Liver Cancer From Major Causes Compared to Smoking and Lung Cancer: A Systematic Review and Meta-Analysis. J Viral Hepat Wallace C, Razavi-Shearer D, Hall S, Asselah T, James C, Kondili LA, Kottilil S, Low-Beer D, Mathur P, Tanaka J, Torres HA, Razavi H. PMID: 42605247 [PubMed - indexed for MEDLINE]
	A novel adrenomedullin receptor signaling-based prognostic model predicts immunosuppressive microenvironment and informs therapeutic stratification in hepatocellular carcinoma: A retrospective bioinformatics study. Medicine (Baltimore) Zhu D, Zhong S, Hong J, Lu C, Zhuang L. PMID: 42601689 [PubMed - indexed for MEDLINE]
	Efficacy analysis of icaritin combined with transarterial chemoembolization in hepatocellular carcinoma stratified by different child-pugh classes. Front Immunol Xu J, Xing Y, Zhao F, Tang B, Li X, Cun J, Lu H, Xia X, Fan H, Gu Y, Xu T. PMID: 42597629 [PubMed - indexed for MEDLINE]
	AI-assisted ascites volumetry for prognostic stratification in HCC treated with Atezolizumab/Bevacizumab. Cancer Imaging Moos M, Bender D, Foerster F, Wiesmann L, Weinmann A, Kloeckner R, Scholz C, Euler A, Mähringer-Kunz A, Bäuerle T, Stoehr F, Hahn F, Müller L. PMID: 42596020 [PubMed - indexed for MEDLINE]
	Cryoablation versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia Mao K, Wang Y, Yao W, Ding J, Ye Z, Ye Y, Zhu R. PMID: 42595456 [PubMed - indexed for MEDLINE]
	Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization - Retrospective Single Center Analysis. J Gastrointest Cancer Schindler A, Beeskow A, Fischer J, Ebel S, Denecke T, Seehofer D, Lincke T, Sabri O, Berg T, van Bömmel F. PMID: 42593561 [PubMed - indexed for MEDLINE]
	Artificial Intelligence for Molecular Biomarker Identification in Gastrointestinal and Hepatobiliary Cancers. Int J Mol Sci Jang HJ, Yim K, Lee SH. PMID: 42589623 [PubMed - indexed for MEDLINE]
	Metabolic Reprogramming at the Tumor-Immune Interface in Hepatocellular Carcinoma. Cells Zhao W, Li P. PMID: 42587767 [PubMed - indexed for MEDLINE]
	Quad-Band Terahertz Metasurface Flexible Biosensor for HCC Biomarker Detection Using a Multipeak Data Fusion Strategy. ACS Appl Mater Interfaces Huang J, Wen P, Liu J, Zhan K, Zhou S, Huang X, Wang Y. PMID: 42587442 [PubMed - indexed for MEDLINE]
	Optimizing liver disease screening and surveillance in remote Indigenous Australian communities: the SSOLID study protocol for multi-methodology research. BMJ Open Mackean T, D'Angelo S, Larkin M, Brown C, Pratt G, Valery PC, Woodman R, Karnon J, Medlin L, Riessen J, Carroll M, Howell J, Jeffrey G, Nugent M, Ivanhoe T, Menzies R, Adams L, Bird G, Campbell K, Durden M, Owen K, Huang RL, Everrett I, Sheppard C, Riessen D, Narayana SK, Wigg A. PMID: 42586727 [PubMed - indexed for MEDLINE]
	Access to the Liver Transplant Waitlist in Patients With HCC: A National EHR Study of Center Level Variation among 11Â 422 Referrals. Clin Transplant Donnelly CB, Mankowski M, Terlizzi K, Patel SS, Eitan T, Long JJ, Liyanage L, Strauss AT, Sacks GD, Orandi BJ, Halazun K, Gentry SE, Segev DL, Massie AB. PMID: 42585195 [PubMed - indexed for MEDLINE]
	The Contribution of CD133 Gene Polymorphisms to Cancer Risk: Integrating Case-Control Evidence WithÂ Meta-Analysis. Genes Chromosomes Cancer Zhang X, Zhou H, Li Y, Chu Y, Li B, Dai J, Yang Q, Feng X, Chen B. PMID: 42583819 [PubMed - indexed for MEDLINE]
	Efficacy and safety of TACE combined with MWA followed by immune checkpoint inhibitors and anti-VEGF/tyrosine kinase inhibitors in hepatocellular carcinoma beyond the up-to-7. Front Immunol Fang Y, Tan J, Su X, Sun M, Zhou X, Zhang S. PMID: 42582241 [PubMed - indexed for MEDLINE]
	Survival outcomes of intensity-modulated radiotherapy combined with immunotherapy and targeted therapy for hepatocellular carcinoma with classification I-IV portal vein tumor thrombus: a propensity score matching study. Front Immunol Chen L, Wei C, Xiao Z, Wu Q, Li L, Xiang B, Guan S, Zhao P, Liang S, Li J. PMID: 42582196 [PubMed - indexed for MEDLINE]
	Solitary Peritoneal Metastasis of AFP-Negative Hepatocellular Carcinoma in a 65-Year-Old Man with a History of Lung Adenocarcinoma: A Case Report. Am J Case Rep Xie Z, Huang J, Fu K. PMID: 42581503 [PubMed - indexed for MEDLINE]
	Temperature-sensitive liquid embolic agent transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for BCLC Stage B/C hepatocellular carcinoma: a multicenter real-world study and spatial transcriptomics profiling (CHANCE 2515). Signal Transduct Target Ther Xie Q, Yang Y, Xie S, Yang X, Gao F, Qi W, Liu H, Liu Y, Deng J, Liu X, Zhou Y, Zhao X, Jiang K, Mao T, Liao X, Dai R, Lyu Y, Cai Y, Xie K, Wu H, Lan T, Liu C, CHANCE2515 Investigators. PMID: 42581040 [PubMed - indexed for MEDLINE]
	From black-box prediction to transparent insight: the status quo and paradigm shift of explainable artificial intelligence in hepatocellular carcinoma research. J Egypt Natl Canc Inst Li Y, Li P. PMID: 42579081 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 77199

Page 1 of 3860



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy